1Masoud Etemadifar, Seyed-Hossein Abtahi,Alireza Dehghania, et al.Myasthenia Gravis during the Course of Neuromyelitis Optica[J]. Neurolo,2011,3:268-273.
2Kay CS, Scola RH, Lorenzoni PJ,et al.NMO-IgG positive neuromyelitis optica in a patient with myasthenia gravis but no thymectomy[J]. J Neurol Sei,2008,15,275:148 - 150.
3Furukawa Y,Yoshikawa H,Yachie A,et al.Neuromyelitis optica associated with myasthenia gravis:characteristic phenotype in Japanese population[J].Eur J Neurol,2006,13:655 - 658.
4Masoud Etemadifar, Seyed-Hossein Abtahi,Alireza Dehghania,et al.Myasthenia Gravis during the Course of Neuromyelitis Optica[J]. Neurolo,2011,3:268-273.
5Uzawa A, Mori M, Arai K, et al.Cytokine and chemokine profiles in neuromyelitis optica:significance of interleukin-6[J].Mult Scler,2010,16:1443 - 1452.
7Thornton IL, Rizzo JF,Cestari DM.Neuromyelitis optica: a review[J]. Semin Ophthalmol,2011,26:337 - 341.
8Hinson SR,Pittock SJ,Lucchinetti CF,et al.Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica[J].Neurology,2007,69:2221 - 2231.
9Vincent A, Palace J, Hilton-Jones D.Myasthenia gravis[J]. Lancet,2001,30(357):2122 - 2128.
10Uzawa A,Mori M,Iwai Y,et al.Association of anti-aquaporin-4 antibody-positive neuromyelitis optica with myasthenia gravis[J].J Neurol Sci,2009,15(287):105 - 107.
